Frontiers in Drug Design and Discovery: Volume 12
eBook - ePub

Frontiers in Drug Design and Discovery: Volume 12

  1. English
  2. ePUB (mobile friendly)
  3. Available on iOS & Android
eBook - ePub

Frontiers in Drug Design and Discovery: Volume 12

About this book

Frontiers in Drug Design and Discovery is a book series devoted to publishing the latest and the most important advances in drug design and discovery. Eminent scientists have contributed chapters focused on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, and structure-activity relationships. This book series should prove to be of interest to all pharmaceutical scientists who are involved in research in drug design and discovery and who wish to keep abreast of rapid and important developments in the field. Volume 12 of this series brings together reviews covering homology modeling and anti-infective drug discovery. Topics included in this volume are: - Homology Modelling: A Computational Tool in Drug Design and Discovery - Anti-trypanosomatid Drugs/Candidates in Clinical Trials: What's New and What's Missing? - Nitroheterocyclics As Anti-Tuberculosis Agents: An Overview - SARS-CoV-2 Protease Inhibitors of Natural Origin: Current Scenario and Future Prospects as Anti-COVID-19 Agents Readership Pharmaceutical scientists, biochemists, researchers in medicine and public health projects

Frequently asked questions

Yes, you can cancel anytime from the Subscription tab in your account settings on the Perlego website. Your subscription will stay active until the end of your current billing period. Learn how to cancel your subscription.
No, books cannot be downloaded as external files, such as PDFs, for use outside of Perlego. However, you can download books within the Perlego app for offline reading on mobile or tablet. Learn more here.
Perlego offers two plans: Essential and Complete
  • Essential is ideal for learners and professionals who enjoy exploring a wide range of subjects. Access the Essential Library with 800,000+ trusted titles and best-sellers across business, personal growth, and the humanities. Includes unlimited reading time and Standard Read Aloud voice.
  • Complete: Perfect for advanced learners and researchers needing full, unrestricted access. Unlock 1.4M+ books across hundreds of subjects, including academic and specialized titles. The Complete Plan also includes advanced features like Premium Read Aloud and Research Assistant.
Both plans are available with monthly, semester, or annual billing cycles.
We are an online textbook subscription service, where you can get access to an entire online library for less than the price of a single book per month. With over 1 million books across 1000+ topics, we’ve got you covered! Learn more here.
Look out for the read-aloud symbol on your next book to see if you can listen to it. The read-aloud tool reads text aloud for you, highlighting the text as it is being read. You can pause it, speed it up and slow it down. Learn more here.
Yes! You can use the Perlego app on both iOS or Android devices to read anytime, anywhere — even offline. Perfect for commutes or when you’re on the go.
Please note we cannot support devices running on iOS 13 and Android 7 or earlier. Learn more about using the app.
Yes, you can access Frontiers in Drug Design and Discovery: Volume 12 by M. Iqbal Choudhary in PDF and/or ePUB format, as well as other popular books in Medicina & Farmacologia. We have over one million books available in our catalogue for you to explore.

Information

Publisher
Bentham Science Publishers
Year
2024
eBook ISBN
9789815165258
Edition
0
Topic
Medicina
Subtopic
Farmacologia

Table of contents

  1. Welcome
  2. Table of Content
  3. Title
  4. BENTHAM SCIENCE PUBLISHERS LTD.
  5. PREFACE
  6. List of Contributors
  7. Homology Modelling: A Computational Tool in Drug Design and Discovery
  8. Anti-trypanosomatid Drugs/Candidates in Clinical Trials: What's New and What's Missing?
  9. Nitroheterocyclics as Anti-Tuberculosis Agents: An Overview
  10. SARS-CoV-2 Protease Inhibitors of Natural Origin: Current Scenario and Future Prospects as Anti-COVID-19 Agents